Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies

被引：3
|
作者：
Machado, Valkiria [1 ]
Cenci, Arthur R. [1 ]
Teixeira, Kerolain F. [1 ]
Sens, Larissa [2 ]
Tizziani, Tiago [2 ]
Nunes, Ricardo J. [2 ]
Ferreira, Leonardo L. G. [3 ]
Yunes, Rosendo A. [2 ]
Sandjo, Louis P. [2 ]
Andricopulo, Adriano D. [3 ]
de Oliveira, Aldo S. [1 ]
机构：
[1] Univ Fed Santa Catarina, Dept Exact Sci & Educ, Rua Joao Pessoa 2514 Bairro Velha, BR-89036004 Blumenau, SC, Brazil
[2] Univ Fed Santa Catarina, Dept Chem, Florianopolis, SC, Brazil
[3] Univ Sao Paulo, Inst Phys Sao Carlos, Ctr Res & Innovat Biodivers & Drug Discovery, Sao Carlos, SP, Brazil
来源：
RSC MEDICINAL CHEMISTRY | 2022年 / 13卷 / 12期
关键词：
ACETYLCHOLINESTERASE; DERIVATIVES;
D O I：
10.1039/d2md00262k
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Alzheimer's disease (AD) is a neurodegenerative disease that is characterized as the main dementia in the elderly. Eighteen pyrazolines were synthesized and evaluated for their inhibitory effects against acetylcholinesterase (AChE) in vitro. Possible interactions between pyrazolines and the enzyme were explored by in silico experiments. Compound 2B of the series was the most active pyrazoline with an IC50 value of 58 nM. Molecular docking studies revealed two important pi-pi interactions with residues Trp 286 and Tyr 341. A correlation between the HOMO-1 surface and AChE inhibition was observed. ADMET assays demonstrated a good profile for compound 2B. From the abovementioned findings, a new avenue of compound 2B analogues could be explored to develop anti-AD agents.
引用
收藏
页码：1644 / 1656
页数：13
相关论文
共 50 条
  • [31] BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides
    Choi, Ran Joo
    Roy, Anupom
    Jung, Hee Jin
    Ali, Md. Yousof
    Min, Byung-Sun
    Park, Chan Hum
    Yokozawa, Takako
    Fan, Tai-Ping
    Choi, Jae Sue
    Jung, Hyun Ah
    JOURNAL OF ETHNOPHARMACOLOGY, 2016, 190 : 219 - 230
  • [32] An Efficient Synthesis of a (-)-Physostigmine's Library for Identifying Potential Anti-Alzheimer's Agents
    Wu, Yi
    Wang, Fusheng
    Song, Hao
    Qin, Yong
    HELVETICA CHIMICA ACTA, 2011, 94 (08) : 1496 - 1505
  • [33] Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies
    Ben Hadda, Taibi
    Deniz, Fatma Sezer Senol
    Orhan, Ilkay Erdogan
    Zgou, Hsaine
    Rauf, Abdur
    Mabkhot, Yahia Nasser
    Bennani, Brahim
    Emam, Dalia R.
    Kheder, Nabila Abdelshafy
    Asayari, Abdulrhman
    Bin Muhsinah, Abdullatif
    Maalik, Aneela
    MEDICINAL CHEMISTRY, 2021, 17 (08) : 834 - 843
  • [34] Novel styryl-thiazole hybrids as potential anti-Alzheimer's agents
    Gouleni, Niki
    Di Rienzo, Annalisa
    Yilmaz, Ahmet
    Selvitopi, Harun
    Arslan, Mehmet Enes
    Mardinoglu, Adil
    Turkez, Hasan
    Di Stefano, Antonio
    Vassiliou, Stamatia
    Cacciatore, Ivana
    RSC MEDICINAL CHEMISTRY, 2023, 14 (11): : 2315 - 2326
  • [35] Investigating the Potential Anti-Alzheimer's Disease Mechanism of Marine Polyphenols: Insights from Network Pharmacology and Molecular Docking
    Youn, Kumju
    Ho, Chi-Tang
    Jun, Mira
    MARINE DRUGS, 2023, 21 (11)
  • [36] Study of a new piperidone as an anti-Alzheimer agent: Molecular docking, electronic and intermolecular interaction investigations by DFT method
    Ramalingam, Arulraj
    Sambandam, Sivakumar
    Medimagh, Mouna
    Al-Dossary, Omar
    Issaoui, Noureddine
    Wojcik, Marek J.
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2021, 33 (08)
  • [37] Naturally occurring multipotent anti-Alzheimer's agents
    Zhang, Hong-Yu
    Yang, Da-Peng
    Ji, Hong-Fang
    EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (03) : 269 - 277
  • [38] In silico molecular studies of natural compounds as possible anti-Alzheimer's agents: ligand-based design
    Iwaloye, Opeyemi
    Elekofehinti, Olusola Olalekan
    Momoh, Abiola Ibrahim
    Babatomiwa, Kikiowo
    Ariyo, Esther Opeyemi
    NETWORK MODELING AND ANALYSIS IN HEALTH INFORMATICS AND BIOINFORMATICS, 2020, 9 (01):
  • [39] In silico molecular studies of natural compounds as possible anti-Alzheimer’s agents: ligand-based design
    Opeyemi Iwaloye
    Olusola Olalekan Elekofehinti
    Abiola Ibrahim Momoh
    Kikiowo Babatomiwa
    Esther Opeyemi Ariyo
    Network Modeling Analysis in Health Informatics and Bioinformatics, 2020, 9
  • [40] Inhibitors of A beta peptide aggregation as potential anti-Alzheimer agents
    Bandiera, T
    Lansen, J
    Post, C
    Varasi, M
    CURRENT MEDICINAL CHEMISTRY, 1997, 4 (03) : 159 - 170
12345